Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk‐based surveillance using pre‐ and post‐treatment general evaluation score. (8th July 2021)
- Record Type:
- Journal Article
- Title:
- Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk‐based surveillance using pre‐ and post‐treatment general evaluation score. (8th July 2021)
- Main Title:
- Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk‐based surveillance using pre‐ and post‐treatment general evaluation score
- Authors:
- Shiha, Gamal
Soliman, Reham
Mikhail, Nabiel
Hassan, Ayman
Eslam, Mohammed - Abstract:
- Abstract: Background and Aims: With the growing number of treated hepatitis C patients, the current 'one‐size‐fits‐all' hepatocellular carcinoma (HCC) surveillance strategies for patients with advanced fibrosis represents a great burden on healthcare systems. An individualized HCC risk strategy incorporates the dynamic changes of HCC risk are lacking. Methods: This single‐centre observational study included 3075 patients, with advanced fibrosis (≥F3) who achieved SVR following DAAs at Egyptian Liver research institute and hospital (ELRIAH) with follow‐up period (range 6‐72 months). The performance of a recently developed General Evaluation Score (GES) HCC risk stratification score was calculated pre‐ and post‐treatment using Harrell's c statistic. Times to HCC and cumulative incidences were calculated with Kaplan–Meier method and compared using log‐rank (Mantel‐Cox) test. Results: Pre‐treatment GES score stratified patients into low (60.4%), intermediate (23.4%), and (16.2%) high‐risk score where 5‐year cumulative incidences of HCC were 1.66%, 4.45% and 7.64%, respectively. Harrell's c statistic was 0.801. Post‐treatment GES score stratified patients into low (57.4%), intermediate (30.7%) and (11.9%) high‐risk score where 5‐year cumulative incidences of HCC were 1.35%, 3.49% and 11.09% respectively. The cumulative HCC incidence increased significantly with higher scores ( P < .001). Harrell's c statistic was 0.818. Using pre‐ and post‐treatment GES score, GES algorithm wasAbstract: Background and Aims: With the growing number of treated hepatitis C patients, the current 'one‐size‐fits‐all' hepatocellular carcinoma (HCC) surveillance strategies for patients with advanced fibrosis represents a great burden on healthcare systems. An individualized HCC risk strategy incorporates the dynamic changes of HCC risk are lacking. Methods: This single‐centre observational study included 3075 patients, with advanced fibrosis (≥F3) who achieved SVR following DAAs at Egyptian Liver research institute and hospital (ELRIAH) with follow‐up period (range 6‐72 months). The performance of a recently developed General Evaluation Score (GES) HCC risk stratification score was calculated pre‐ and post‐treatment using Harrell's c statistic. Times to HCC and cumulative incidences were calculated with Kaplan–Meier method and compared using log‐rank (Mantel‐Cox) test. Results: Pre‐treatment GES score stratified patients into low (60.4%), intermediate (23.4%), and (16.2%) high‐risk score where 5‐year cumulative incidences of HCC were 1.66%, 4.45% and 7.64%, respectively. Harrell's c statistic was 0.801. Post‐treatment GES score stratified patients into low (57.4%), intermediate (30.7%) and (11.9%) high‐risk score where 5‐year cumulative incidences of HCC were 1.35%, 3.49% and 11.09% respectively. The cumulative HCC incidence increased significantly with higher scores ( P < .001). Harrell's c statistic was 0.818. Using pre‐ and post‐treatment GES score, GES algorithm was developed with higher predictive value. The cumulative HCC incidence increased significantly with higher scores ( P < .001). Harrell's c statistic was 0.832. Conclusion: A dynamic algorithm incorporating both pre‐ and post‐GES scores have better performance and predictive value compared with only pre‐treatment assessments. The proposed algorithm would help to stratify those who need intensive or being excluded from screening. … (more)
- Is Part Of:
- Liver international. Volume 41:Number 11(2021)
- Journal:
- Liver international
- Issue:
- Volume 41:Number 11(2021)
- Issue Display:
- Volume 41, Issue 11 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 11
- Issue Sort Value:
- 2021-0041-0011-0000
- Page Start:
- 2768
- Page End:
- 2776
- Publication Date:
- 2021-07-08
- Subjects:
- CHC -- DAAs -- Dynamic changes -- HCC risk score
Liver -- Periodicals
Liver -- Diseases -- Periodicals
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1478-3231 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/liv.14995 ↗
- Languages:
- English
- ISSNs:
- 1478-3223
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5280.514000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 27130.xml